BAttLe Against COVID-19 Using MesenchYmal Stromal Cells
Status:
Suspended
Trial end date:
2021-09-30
Target enrollment:
Participant gender:
Summary
The investigational medicinal product consists of expanded allogeneic mesenchymal stromal
cells derived from adipose tissue and administered intravenously.
The objective of this project is to evaluate the safety and efficacy of the administration of
expanded allogeneic adipose tissue adult mesenchymal stem cells, in patients infected with
SARS-COV-2 with COVID-19 type complications.
Phase:
Phase 2
Details
Lead Sponsor:
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Collaborators:
Clinica Universidad de Navarra, Universidad de Navarra Hospital Clínico Universitario Virgen de la Arrixaca Hospital General Universitario de Alicante Hospital General Universitario Gregorio Marañon Hospital Universitario de Salamanca Instituto de Investigación Sanitaria y Biomédica de Alicante University of Salamanca